ADAs to Alemtuzumab

Clinical trial NCT06310343 · COMPLETED

Trial details

NCT number: NCT06310343
Sponsor: Queen Mary University of London
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2022-07-12
Primary completion: 2025-10-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.